CTOs on the Move

Franklin and Seidelmann Subspecialty Radiology

www.fs-rad.com

 
Franklin and Seidelmann Subspecialty Radiology LLC is a Beachwood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.fs-rad.com
  • 23625 Commerce Park Ste 204
    Beachwood, OH USA 44122
  • Phone: 216.255.5701

Executives

Name Title Contact Details

Similar Companies

A T VILLA USA INC

A T VILLA USA INC is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prime Pathology Laboratories

Prime Pathology Laboratories is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Good Start Genetics

Good Start Genetics is an innovative molecular diagnostics company harnessing a powerful, proprietary next-generation DNA sequencing (NGS) capability combined with other technologies to deliver best-in-class tests for routine genetic screening. Through its GoodStart Select(TM) offering, the company provides the most comprehensive and clinically actionable set of tests for known and novel mutations that cause inherited diseases. Good Start`s NGS capabilities can be applied to multiple disease areas, including pre-conception carrier screening in the in-vitro fertilization setting.

Protasis

Protasis is a Marlborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Abcam

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research. We are headquartered in Cambridge UK. Our eight additional sales, production, and distribution offices are located in Asia, UK, and the USA.   Our mission is to help scientists to discover more. Our vision is to be the brand most recommended by life science researchers.   We recognise the importance of providing clear and timely information to our existing and potential shareholders and hope that you will find this website helpful on informing your investment decisions.